EAPH - Easton Pharmaceuticals Inc.
| Previous Close | 0.0172 |
| Open | 0.0000 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0000 - 0.0000 |
| 52 Week Range | |
| Volume | 0 |
| Avg. Volume | 2,437,508 |
| Market Cap | 19.919M |
| Beta | -3.79 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0010 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire•8 days ago
Easton Pharmaceuticals Announces it is Moving Towards a Letter of Intent With an AMPR Applicant Towards a Marijuana Cultivators / Growers License for Canada; Provides Other Updates
TORONTO, ON, April 17, 2018-- Easton Pharmaceuticals Inc. announces it is moving towards a letter of intent after initiating negotiations with 2 AMPR applicants, one having received a Health Canada Compliance ...
- GlobeNewswire•9 days ago
Easton Pharmaceuticals Announces BAYER Agreement Update
TORONTO, ON, April 16, 2018-- Easton Pharmaceuticals Inc. Announces update to its signed agreement with BAYER’ s subsidiary company, Bayer Consumer Care. As previously announced, Easton Pharmaceuticals, ...
- GlobeNewswire•last month
Easton Pharmaceuticals Announces Development of a Blockchain and Cryptocurrency Initiative
TORONTO, ON, March 21, 2018-- Easton Pharmaceuticals, Inc., announces it has initiated discussions for the development of a blockchain platform and cryptocurrency that will streamline the supply chain ...
- GlobeNewswire•last month
Easton Pharmaceuticals Announces It Has Commenced Negotiations With An AMPR Applicant Towards a Marijuana Cultivators / Growers License For Canada; Provides iBliss Update
TORONTO, ON, March 14, 2018-- Easton Pharmaceuticals Inc. announces it has commenced negotiations with an AMPR applicant towards a Canadian Marijuana cultivators/ growers license. Building on its medical ...
- GlobeNewswire•2 months ago
Easton Pharmaceuticals Announces Key Management Addition With the Appointment of Dr. Daniel Bagi, M.D. to the Board of Directors; Provides Other Updates
TORONTO, ON, Feb. 20, 2018-- Easton Pharmaceuticals announces the appointment of Dr. Daniel Bagi, MD as Director, President of Business Development. Daniel Bagi is a senior executive physician with 27 ...
- GlobeNewswire•3 months ago
Easton Pharmaceuticals Announces Negotiations for a New Sub-Distribution Agreement for One of Its Woman’s Diagnostic / Treatment Products & Provides Update on Its Alliance Operations
TORONTO, ON, Feb. 06, 2018-- Easton Pharmaceuticals, Inc., announces it has initiated discussions to transfer part of its licensed woman’ s diagnostic and treatment products to another company including ...
- GlobeNewswire•3 months ago
Easton Pharmaceuticals Announces The Signing Of Closed Sub-Distribution Agreement for Product VS-Sense
Agreement Terms Include Several Up-Front Cash Payments Based On Milestones And A Time Limited Recurring Royalty Payment on Each Product Sold. TORONTO, ON, Jan. 25, 2018-- Easton Pharmaceuticals, Inc. and ...
- Marketwired•6 months ago
Easton Pharmaceuticals Announces Final Payment Completing $1.3 Million JV Agreement With Alliance Group For a 50% Property Ownership Interest and Various Businesses Including The Cultivation of Medical / Recreational Marijuana For National Canadian Market
Easton Pharmaceuticals, Inc. is pleased to announce its final payment which completes its $1.3 Million CDN JV agreement with Canadian based 1124123 Ontario Limited towards a 50% property ownership interest ...
- Marketwired•6 months ago
Easton Pharmaceuticals & JV Partner Alliance Group Announces It Has Cleared Final Hurdles Toward Allowing For The Cultivation of Medical / Recreational Marijuana For National Canadian Market
Easton Pharmaceuticals, Inc. , is pleased to announce, pursuant to its previously announced closed agreement with Canadian based -- 1124123 Ontario Limited -- that its legal team has notified Easton / ...
- Marketwired•7 months ago
Easton Pharmaceuticals Announces That Its Partner Windsor Pharmaceuticals Has Received Regulatory Approvals For Products VS-Sense and AL-Sense For Central America and The Caribbean
Easton Pharmaceuticals Inc. and its JV partner BMV Medica SA de CV announces that its distributor Windsor Pharmaceuticals SA has received regulatory approval for two of its exclusively licensed Women's ...
- Marketwired•8 months ago
Easton Pharmaceuticals Announces $1,000,000 cdn In Payments Toward Alliance Group JV / Partnership Agreement; Announces $8,000,000 cdn Aggregate LOI Contract
Easton Pharmaceuticals, Inc. , is pleased to announce, pursuant to its previously announced Closing Agreement with Canadian based 124123 Ontario Inc. , Easton has advanced $1,000,000 cdn in payments to ...
- Marketwired•8 months ago
Easton Pharmaceuticals and Alliance Group Announces the Closing Of Its First Aggregate Contract Valued At $6,000,000 CDN On Its 90 Acre Portion Of Industrial Zoned Land
Easton Pharmaceuticals, Inc. , is pleased to announce, pursuant to its previously announced Closing with Canadian based, joint venture partner, 1124123 Ontario Limited -- executes $6,000,000 CDN aggregate ...
- Marketwired•8 months ago
Easton Pharmaceuticals Announces Advancing $575,000 Payment Towards Closed Agreement With Alliance Group For The Cultivation Of Medical / Recreational Marijuana For Canada and Other Revenue Producing Businesses
Easton Pharmaceuticals, Inc. , pursuant to its previously announced closing agreement with Canadian based -- Alliance Group -- Easton has advanced $575,000 towards its acquired interest in 45 acres of ...
- Marketwired•8 months ago
Easton Pharmaceuticals Announces Finalized Sub-Distribution Agreement With Gedeon Richter S.A.P.I de C.V. For Product Launch Of AmnioSense (AL-Sense)
Easton Pharmaceuticals Inc. Announces execution and closing of sub-distribution agreement with Gedeon Richter Plc and its Mexican subsidiary company Gedeon Richter S.A.P.I de C.V. for the product "AmnioSense."...
- Marketwired•9 months ago
Easton Pharmaceuticals Provides Shareholder Update On Acquisitions, Its Recent MMJ Initiative And Progress On Its Woman's Diagnostics and Treatment Segment
Easton Pharmaceuticals Inc. provides shareholder update on new and existing acquisitions including its medical marijuana venture and progress on its woman's diagnostics and treatment segment products.
- Marketwired•10 months ago
Easton Pharmaceuticals Announces It Has Received $400,000 USD In Product Purchase Orders For The Current Quarter From Its Woman's Diagnostic And Treatment Products Business For The Mexico Market
Easton Pharmaceuticals, Inc. , is pleased to announce it has received an approximate total of $400,000 USD in purchase orders for the quarter from its sub-distributors for the Mexican market.
- Marketwired•10 months ago
Easton Pharmaceuticals Announces It Has Finalized Agreement Terms With Alliance Group For Ownership Stake in Several Businesses On 45 Acres Of Agricultural Land, Which Includes The Cultivation of Medical Marijuana For National Canadian Market
Easton Pharmaceuticals, Inc. , is pleased to announce, pursuant to its previously announced Letter of Intent with Canadian based -- Alliance Group -- final Terms have been mutually agreed to on a final ...
- Marketwired•11 months ago
Easton Pharmaceuticals Announces It Has Signed an LOI to Acquire An Interest in a 45 Acre Parcel for the Cultivation of Medical Marijuana in Toronto, Canada; Wholly Owned Subsidiary, iBliss in Birmingham's UK Vaper Expo
Easton Pharmaceuticals, Inc. is pleased to announce that it has signed a Letter of Intent with Canadian Alliance Group to acquire an interest in their 45 acre fully owned parcel of land for the cultivation, ...
- Marketwired•11 months ago
Easton Pharmaceuticals Announces Formally Accepting Proposal For The Sub-Licensing Of Product VS-Sense From German based Multi-National Pharmaceutical Company For Mexico; Agreement Includes An Up-Front Cash Payment And a Recurring Royalty
Easton Pharmaceuticals, Inc. , announces that Easton / BMV Medica have formally accepted a proposal for the sub-licensing of product VS-Sense from a German based multi-national pharmaceutical company for ...
- Marketwired•last year
Easton Pharmaceuticals Announces Signing LOI For The Acquisition Of Revenue Producing, Israel Based Therapeutics Company, Herbs Of Kedem
Easton Pharmaceuticals, Inc. announces it has signed an LOI for the acquisition of revenue producing, Israel based therapeutics company, Herbs of Kedem.